Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 10, Issue 1, Pages 61
Publisher
Springer Nature
Online
2011-07-08
DOI
10.1186/1475-2840-10-61
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
- (2011) Robert Ratner et al. Cardiovascular Diabetology
- The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an "Endothelial Resistance" to Glucagon-Like Peptide 1 in Diabetes
- (2011) A. Ceriello et al. DIABETES CARE
- Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects
- (2010) Aidar R. Gosmanov et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Nutrient Modification of the Innate Immune Response
- (2010) Eric A. Schwartz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
- (2010) Que Liu et al. Cardiovascular Diabetology
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
- (2010) M. Arakawa et al. DIABETES
- Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
- (2010) J. Koska et al. DIABETES CARE
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
- (2010) Debora Williams-Herman et al. BMC Endocrine Disorders
- Endothelial Function Predicts Progression of Carotid Intima-Media Thickness
- (2009) Julian P.J. Halcox et al. CIRCULATION
- The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers
- (2009) Katsuyuki Nakajima et al. CLINICA CHIMICA ACTA
- The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice
- (2009) J. Hsieh et al. DIABETOLOGIA
- Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
- (2008) Antonio Cervera et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome
- (2008) Martin Adiels et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma Levels of HDL Subpopulations and Remnant Lipoproteins Predict the Extent of Angiographically-Defined Coronary Artery Disease in Postmenopausal Women
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- New Drugs for the Treatment of Diabetes
- (2008) Silvio E. Inzucchi et al. CIRCULATION
- Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted
- (2008) Akio Kawakami et al. CIRCULATION RESEARCH
- Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: A randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study
- (2008) Sherwyn L. Schwartz et al. CLINICAL THERAPEUTICS
- Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study
- (2008) Ralph A. DeFronzo et al. CURRENT MEDICAL RESEARCH AND OPINION
- Glycemic Control in Diabetes: A Tale of Three Studies
- (2008) Z. T. Bloomgarden DIABETES CARE
- Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population
- (2008) Jacob J. Freiberg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Regulation of Islet Hormone Release and Gastric Emptying by Endogenous Glucagon-Like Peptide 1 after Glucose Ingestion
- (2008) Marzieh Salehi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The incretin system and its role in type 2 diabetes mellitus
- (2008) J HOLST et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now